Atlas Trials

The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure

Clinical trial NCT02129179 · COMPLETED

Trial details

NCT number
NCT02129179
Sponsor
Papworth Hospital NHS Foundation Trust
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure
Start date
2014-06-01
Primary completion
2016-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.